Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. To help realize our ambitions, the argenx Global Commercial Team is looking for a Director, Global Indication Lead, Rheumatology. In this key role, you will be responsible for leading the development of the commercial strategy for our key asset in one or multiple late-stage clinical development programs which include for example Sjogren’s Disease and Myositis. You will guide the development and integrated execution of pre-launch efforts of the cross-functional Indication Commercialization Team in/for the assigned indication(s). This role can be based virtually or on-site, ideally within proximity to one of our European, or East Coast US based hubs.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
1,001-5,000 employees